Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: The Western New York Exposures and Breast Cancer (WEB) Study

Breast Cancer Research and Treatment

Volumn 126, Issue 1, 2011, Pages 157-165

  Brasky, Theodore M ^a,e   Bonner, Matthew R ^a   Moysich, Kirsten B ^b   Ochs Balcom, Heather M ^a   Marian, Catalin ^c   Ambrosone, Christine B ^b   Nie, Jing ^a   Tao, Meng Hua ^a   Edge, Stephen B ^b   Trevisan, Maurizio ^d   Shields, Peter G ^c   Freudenheim, Jo L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d Nevada System of Higher Education   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Breast cancer; Cyclooxygenase 2; Non steroidal anti inflammatory drugs; Prostaglandinendoperoxide synthase 2; Single nucleotide polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CONTROLLED STUDY; DRUG EXPOSURE; DRUG PROTEIN BINDING; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CLINICAL TRIALS, PHASE II AS TOPIC; CYCLOOXYGENASE 2; DNA, NEOPLASM; FEMALE; HUMANS; IBUPROFEN; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 79151480156     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1082-x     Document Type: Article

References (37)

1. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 860 867 1:CAS:528:DC%2BD38XpsFygtb4%3D 10.1038/nature01322 12490959 (see comment) (Pubitemid 36019639)
2. B Takkouche C Regueira-Méndez M Etminan 2008 Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis J Natl Cancer Inst 100 1420 1423 10.1093/jnci/djn347
3. Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, Edge SB, Kallakury BV, Marian C, Trevisan M, Shields PG, Freudenheim JL (2010) Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes Control. doi: 10.1007/s10552-010-9579-5
4. T Kosaka A Miyata H Ihara S Hara T Sugimoto O Takeda E Takahashi T Tanabe 1994 Characterization of the human gene (PTGS2) encoding prostaglandin- endoperoxide synthase 2 Eur J Biochem 221 889 897 1:CAS:528:DyaK2cXltVSqsb8%3D 10.1111/j.1432-1033.1994.tb18804.x 8181472 (Pubitemid 24146188)
5. LR Howe 2007 Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer Breast Cancer Res 9 210 10.1186/bcr1678 17640394
6. E Half XM Tang K Gwyn A Sahin K Wathen FA Sinicrope 2002 Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ Cancer Res 62 1676 1681 1:CAS:528:DC%2BD38XisVSisb4%3D 11912139 (Pubitemid 34408488)
7. D Hwang D Scollard J Byrne E Levine 1998 Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer J Natl Cancer Inst 90 455 460 1:STN:280:DyaK1c7otVCltw%3D%3D 10.1093/jnci/90.6.455 9521170 (Pubitemid 28160637)
8. C Leo S Faber B Hentschel M Hockel L-C Horn 2006 The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue Ann Diagn Pathol 10 327 332 10.1016/j.anndiagpath.2006.03.002 17126249 (Pubitemid 44765274)
9. JE Abraham P Harrington KE Driver J Tyrer DF Easton AM Dunning PD Pharoah 2009 Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival Clin Cancer Res 15 2181 2191 1:CAS:528:DC%2BD1MXjtF2ru7Y%3D 10.1158/1078-0432.CCR-08-0716 19276290
10. DG Cox J Buring SE Hankinson DJ Hunter 2007 A polymorphism in the 3 untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study Breast Cancer Res 9 R3 10.1186/bcr1635 17214885 (Pubitemid 350215158)
11. L Gallicchio MA McSorley CJ Newschaffer LW Thuita H-Y Huang SC Hoffman KJ Helzlsouer 2006 Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease Cancer 106 1443 1452 1:CAS:528:DC%2BD28XjsFerurw%3D 10.1002/cncr.21763 16502408 (Pubitemid 44202808)
12. J Gao Q Ke H-X Ma Y Wang Y Zhou Z-B Hu X-J Zhai X-C Wang J-W Qing W-S Chen G-F Jin J-Y Liu Y-F Tan X-R Wang H-B Shen 2007 Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population J Toxicol Environ Health A 70 908 915 10.1080/15287390701289966 17479405 (Pubitemid 46699715)
13. U Langsenlehner B Yazdani-Biuki T Eder W Renner TC Wascher B Paulweber W Weitzer H Samonigg P Krippl 2006 The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk Clin Cancer Res 12 1392 1394 1:CAS:528:DC%2BD28XhsFalurk%3D 10.1158/1078-0432.CCR-05-2055 16489098 (Pubitemid 43342533)
14. PG Moorman J Sesay V Nwosu JG Kane AR de Cotret K Worley R Millikan 2005 Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women Cancer Epidemiol Biomarkers Prev 14 3013 3014 1:CAS:528:DC%2BD2MXhtlahs7jL 10.1158/1055-9965.EPI-05-0291 16365029 (Pubitemid 43068842)
15. J Shen MD Gammon MB Terry SL Teitelbaum AI Neugut RM Santella 2006 Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk Breast Cancer Res 8 R71 10.1186/bcr1629 17181859 (Pubitemid 350201710)
16. U Vogel J Christensen BA Nexo H Wallin S Friis A Tjonneland 2007 Peroxisome profilerator-activated receptorgamma2 Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes Carcinogenesis 28 427 434 1:CAS:528: DC%2BD2sXhs1Srs7o%3D 10.1093/carcin/bgl170 16959787 (Pubitemid 46321860)
17. F Li G-S Ren HY Li XY Wang L Chen J Li 2009 A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer Clin Oncol 21 302 305 1:STN:280:DC%2BD1M3jvVKltA%3D%3D 10.1016/j.clon.2008.12.005
18. L Dossus R Kaaks F Canzian D Albanes SI Berndt H Boeing J Buring SJ Chanock F Clavel-Chapelon HS Feigelson JM Gaziano E Giovannucci C Gonzalez CA Haiman G Hallmans SE Hankinson RB Hayes BE Henderson RN Hoover DJ Hunter KT Khaw LN Kolonel P Kraft J Ma L Le Marchand E Lund PH Peeters M Stampfer DO Stram G Thomas MJ Thun A Tjonneland D Trichopoulos R Tumino E Riboli J Virtamo SJ Weinstein M Yeager RG Ziegler DG Cox 2009 PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3) Carcinogenesis 31 3 455 461 10.1093/carcin/bgp307 19965896 (Pubitemid 351196355)
19. Burke A, Smyth E, FitzGerald GA (2006) Analgesic-antipyretic agents: pharmacotherapy of gout. In: Brunton LL, Lazlo JS, Parker KL (eds) Goodman & Gilman's the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York, pp 671-716
20. MR Bonner D Han J Nie P Rogerson JE Vena P Muti M Trevisan SB Edge JL Freudenheim 2005 Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure Cancer Epidemiol Biomarkers Prev 14 53 60 1:CAS:528:DC%2BD2MXmsVOksw%3D%3D 15668476 (Pubitemid 40165283)
21. MR Bonner J Nie D Han JE Vena P Rogerson P Muti M Trevisan SB Edge JL Freudenheim 2005 Secondhand smoke exposure in early life and the risk of breast cancer among never smokers (United States) Cancer Causes Control 16 683 689 10.1007/s10552-005-1906-x 16049807 (Pubitemid 41110959)
22. SE McCann C Ip MM Ip MK McGuire P Muti SB Edge M Trevisan JL Freudenheim 2004 Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study) Cancer Epidemiol Biomarkers Prev 13 1480 1484 1:CAS:528: DC%2BD2cXntFCksLo%3D 15342449 (Pubitemid 39202315)
23. D Han J Nie MR Bonner SE McCann P Muti M Trevisan FA Ramirez-Marrero D Vito JL Freudenheim 2006 Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study Int J Cancer 119 2931 2937 1:CAS:528:DC%2BD28Xht1yqt7nI 10.1002/ijc.22236 17016824 (Pubitemid 44846247)
24. EV Hersh PA Moore GL Ross 2000 Over-the-counter analgesics and antipyretics: a critical assessment Clin Ther 22 500 548 1:CAS:528: DC%2BD3cXksVCrtrY%3D 10.1016/S0149-2918(00)80043-0 10868553 (Pubitemid 30434308)
25. International HapMap Consortium KA Frazer DG Ballinger DR Cox DA Hinds LL Stuve RA Gibbs JW Belmont A Boudreau P Hardenbol SM Leal S Pasternak DA Wheeler TD Willis F Yu H Yang C Zeng Y Gao H Hu W Hu C Li W Lin S Liu H Pan X Tang J Wang W Wang J Yu B Zhang Q Zhang H Zhao H Zhao J Zhou SB Gabriel R Barry B Blumenstiel A Camargo M Defelice M Faggart M Goyette S Gupta J Moore H Nguyen RC Onofrio M Parkin J Roy E Stahl E Winchester L Ziaugra D Altshuler Y Shen Z Yao W Huang X Chu Y He L Jin Y Liu Y Shen W Sun H Wang Y Wang Y Wang X Xiong L Xu MMY Waye SKW Tsui H Xue JT-F Wong LM Galver J-B Fan K Gunderson SS Murray AR Oliphant MS Chee A Montpetit F Chagnon V Ferretti M Leboeuf J-F Olivier MS Phillips S Roumy C Sallee A Verner TJ Hudson P-Y Kwok D Cai DC Koboldt RD Miller L Pawlikowska P Taillon-Miller M Xiao L-C Tsui W Mak YQ Song PKH Tam Y Nakamura T Kawaguchi T Kitamoto T Morizono A Nagashima, et al. 2007 A second generation human haplotype map of over 3.1 million SNPs Nature 449 851 861 1:CAS:528:DC%2BD2sXhtFOjt7jL 10.1038/nature06258 17943122 (Pubitemid 47598626)
26. PIW de Bakker R Yelensky I Pe'er SB Gabriel MJ Daly D Altshuler 2005 Efficiency and power in genetic association studies Nat Genet 37 1217 1223 10.1038/ng1669 16244653 (see comment) (Pubitemid 41568704)
27. X Zhang X Miao W Tan B Ning Z Liu Y Hong W Song Y Guo X Zhang Y Shen B Qiang FF Kadlubar D Lin 2005 Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer Gastroenterology 129 565 576 1:CAS:528:DC%2BD2MXpvVWmsbw%3D 16083713 (Pubitemid 41096644)
28. A Papafili MR Hill DJ Brull RJ McAnulty RP Marshall SE Humphries GJ Laurent 2002 Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response Arterioscler Thromb Vasc Biol 22 1631 1636 1:CAS:528:DC%2BD38XnsVKrtr8%3D 10.1161/01.ATV.0000030340.80207.C5 12377741 (see comment)
29. F Dudbridge 2003 Pedigree disequilibrium tests for multilocus haplotypes Genet Epidemiol 25 115 121 10.1002/gepi.10252 12916020 (Pubitemid 37064867)
30. W Zhu B Wei X Shan 2010 765>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies Mol Biol Rep 37 277 288 1:CAS:528:DC%2BC3cXisFWisg%3D%3D 10.1007/s11033-009-9685-1 19669667
31. I Cheng X Liu SJ Plummer LM Krumroy G Casey JS Witte 2007 COX2 genetic variation, NSAIDs, and advanced prostate cancer risk Br J Cancer 97 557 561 1:CAS:528:DC%2BD2sXptVWjurk%3D 10.1038/sj.bjc.6603874 17609663 (Pubitemid 47258446)
32. E Fritsche SJ Baek LM King DC Zeldin TE Eling DA Bell 2001 Functional characterization of cyclooxygenase-2 polymorphisms J Pharmacol Exp Ther 299 468 476 1:CAS:528:DC%2BD3MXnvV2qsb0%3D 11602656 (Pubitemid 32979657)
33. DA Dixon 2004 Dysregulated post-transcriptional control of COX-2 gene expression in cancer Curr Pharm Des 10 635 646 1:CAS:528:DC%2BD2cXhvFOku78%3D 10.2174/1381612043453171 14965326 (Pubitemid 38292390)
34. SJ Cok AR Morrison 2001 The 3-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency J Biol Chem 276 23179 23185 1:CAS:528:DC%2BD3MXkvValsrs%3D 10.1074/jbc.M008461200 11294846 (Pubitemid 37411015)
35. S Wacholder N Rothman N Caporaso 2000 Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias J Natl Cancer Inst 92 1151 1158 1:STN:280:DC%2BD3cvlvFeguw%3D%3D 10.1093/jnci/92.14.1151 10904088 (see comment)
36. S Wacholder P Hartge JH Lubin M Dosemeci 1995 Non-differential misclassification and bias towards the null: a clarification Occup Environ Med 52 557 558 1:STN:280:DyaK2Mzpt1Ojtg%3D%3D 10.1136/oem.52.8.557 7663646 (see comment)
37. LM Morimoto E White PA Newcomb 2003 Selection bias in the assessment of gene-environment interaction in case-control studies Am J Epidemiol 158 259 263 10.1093/aje/kwg147 12882948 (Pubitemid 36944419)